FaceYa FaceYa
Resultados de pesquisa
Veja todos os resultados
  • Acessar
    Entrar
    Cadastrar
    Pesquisar
    Theme Switcher
    Night Mode

Pesquisar

Conheça novas pessoas, crie conexões e faça novos amigos

  • Feed de notícias
  • EXPLORAR
  • Páginas
  • Grupos
  • Eventos
  • Blogs
  • Offers
  • Jobs
  • Courses
  • Fóruns
  • Filmes
  • Jogos
  • Publicações
  • Blogs
  • Usuários
  • Páginas
  • Grupos
  • Eventos
  • Wang Judy adicionou um novo artigo Outro
    2026-05-28 08:09:27 -
    New Application Scenarios for the AS01 Adjuvant: The ACI-24.060 Alzheimer’s Disease Vaccine Project
    The treatment of Alzheimer’s Disease (AD) has entered the era of "Disease-Modifying Therapies" (DMTs). With the approval of anti-Aβ monoclonal antibodies (such as Lecanemab), the Amyloid Cascade Hypothesis has received clinical validation. However, the safety risks associated with ARIA (Amyloid-Related Imaging Abnormalities) in monoclonal antibody therapies, as well as their high...
    0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
    Faça o login para curtir, compartilhar e comentar!
  • Wang Judy adicionou um novo artigo Outro
    2026-06-10 06:59:58 -
    The Potential and Advantages of Using the AS01 Adjuvant in Next-Generation Adjuvanted Influenza Vaccines
    Influenza vaccines represent one of the largest segments of the global vaccine market (with the global market size exceeding $8 billion by 2025). However, the protective efficacy of traditional split-virus vaccines has long hovered between 30% and 50% among individuals aged 65 and older and immunocompromised populations. Additionally, these vaccines require annual updates, offer short-term...
    0 Comentários 0 Compartilhamentos 1KB Visualizações 0 Anterior
    Faça o login para curtir, compartilhar e comentar!
© 2026 FaceYa Portuguese (Brazil)
English Arabic French Spanish Portuguese Deutsch Turkish Dutch Italiano Russian Romaian Portuguese (Brazil) Greek 简体中文 日本語 한국어 繁体中文
Sobre Termos Privacidade Fale conosco Diretório